/Companies

NeuroPace

NASDAQ: NPCE

Mountain View, US · Founded 1999 · Delaware corporation · 245 employees on LinkedIn · 3 known investors

Find your way into NeuroPace

Sign up to see every warm intro you have to NeuroPace

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroPace team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.

Founders & leadership

RKRebecca Kuhn
Rebecca KuhnSenior Strategic Advisor - Finance2025–2026Rebecca Kuhn is Chief Financial Officer of NeuroPace, a medical device company developing brain-responsive neurostimulation treatment for drug-resistant epilepsy. She has led finance and administrative functions across multiple stages of company growth, including IPO preparation and execution, and has experience building finance teams at healthcare organizations.
FFFrank Fischer
Frank FischerExecutive
JBJoel Becker
Joel BeckerPresident and CEOJoel Becker is President, CEO, and Director of NeuroPace, a medical device company developing the RNS System, a brain-responsive neurostimulation platform for treating drug-resistant epilepsy and other neurological disorders.
VBVince Burgess
Vince BurgessBoard Member2017–2020Director at Acutus Medical
RRRenee Ryan
Renee RyanBoard Member (Audit and Compensation Committees)Investor at DigitalDx Ventures
RL
Ray LarkinNamed on SEC filing
GG
Greg GarfieldNamed on SEC filing
MF
Mike FavetNamed on SEC filing
NK
Nael KassarNamed on SEC filing

Board

JSJonathan Silverstein
Jonathan SilversteinBoard directorPartner at OrbiMed
JL
Joseph LacobBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$141.4M disclosed across 2 rounds · 2016–2020

▶$69.4MraisedAug 2020 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nael KassarDirector
  • Rebecca KuhnExecutive Officer
  • Mike FavetExecutive Officer, Director
  • Frank FischerExecutive Officer, Director
  • Greg GarfieldDirector
  • Renee RyanDirector
  • Rishi GuptaDirector
  • Vince BurgessDirector
  • Evan NortonDirector
  • Joseph LacobDirector
Offering amount
$96.4M
Amount sold
$69.4M
Finders' fees
$663.4K
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$72MraisedAug 2017 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rebecca KuhnExecutive Officer
  • Vince BurgessDirector
  • Renee RyanDirector
  • Ray LarkinDirector
  • Jonathan SilversteinDirector
  • Frank FischerExecutive Officer, Director
  • Joseph LacobDirector
  • Greg GarfieldDirector
  • Mike FavetDirector
  • Nael KassarDirector
Offering amount
$80M
Amount sold
$72M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through NeuroPace went on to found or lead other companies.

Related companies · 3

Companies working in the same space as NeuroPace.

In the news

Frequently asked questions

What does NeuroPace do?
NeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Who are NeuroPace's investors?
NeuroPace's investors include Accelmed Partners, New Enterprise Associates (NEA), OrbiMed.
How much funding has NeuroPace raised?
NeuroPace has disclosed $141.4M raised across 2 rounds.
Where is NeuroPace headquartered?
NeuroPace is headquartered in Mountain View, US.